Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01596582 · ClinicalTrials.gov registry record · NA
Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT01596582 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 352 participants.
The verdict
NCT01596582, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
Shared decision-making (SDM) has been advocated as a strategy for increasing colorectal cancer (CRC) screening rates. Our studies to date suggest that while the use of a novel computer-based decision aid facilitates several components of SDM from both the patient and provider perspective, there is a reluctance among providers to acquiesce to patient preferences for a particular screening strategy when its differs from their own. The overall objective of this study is to assess whether risk stratification for advanced colorectal neoplasia influences clinical decision-making related to screening test selection and adherence within a SDM framework. Eligible subjects will be randomized to either an experimental arm, in which they will be asked to complete a 6-item risk assessment questionnaire known as the "Advanced Colorectal Neoplasia Index \[ACNI\]" after reviewing a web-based decision aid, or a control arm, in which they will only review the decision aid. Both interventions will take place just before a prearranged office visit with their provider. The primary outcome will be screening test ordered; secondary outcomes will include test completion rates, concordance between test preference and test ordered,, patient satisfaction with decision-making process, screening intentions, 6-month test completion rates and provider satisfaction. Outcomes will be evaluated using computerized tracking systems or validated instruments.
Interventions
- BEHAVIORAL Risk Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01596582
The ClinicalTrials.gov registry entry for NCT01596582 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Risk Assessment is the first listed.
NCT01596582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01596582 about?
NCT01596582 is a clinical study titled "Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening". Shared decision-making (SDM) has been advocated as a strategy for increasing colorectal cancer (CRC) screening rates. Our studies to date suggest that while the use of a novel computer-based decision aid facilitates several components of SDM from both the patient and provider perspective, there is a...
What is the current status of trial NCT01596582?
This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2012-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01596582?
The interventions under investigation include: Risk Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01596582?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.